Table 1.
1-, 1.5-, 2-, 3-, 5-, 10-, and 15-year relative survival rates with 95% confidence intervals for all primary brain tumors: 1985–2005
| Category | Cases n | Relative survival, % |
||||||
|---|---|---|---|---|---|---|---|---|
| 1 year | 1.5 years | 2 years | 3 years | 5 years | 10 years | 15 years | ||
| All brain tumors | 22,974 | 67.8 (67.2–68.4) | 61.6 (61.0–62.3) | 58.6 (57.9–59.2) | 55.7 (55.0–56.4) | 52.6 (51.9–53.4) | 49.5 (48.6–50.4) | 47.2 (46.1–48.4) |
| Tumor behavior | ||||||||
| Malignant | 14,119 | 52.3 (51.4–53.1) | 42.5 (41.7–43.3) | 37.8 (37.0–38.6) | 33.7 (32.8–34.5) | 29.8 (28.9–30.6) | 26.9 (25.9–27.8) | 26.1 (25.0–27.2) |
| Nonmalignant | 8,855 | 92.8 (92.2–93.4) | 92.5 (91.8–93.1) | 92.1 (91.4–92.8) | 91.6 (90.8–92.3) | 90.0 (89.0–90.9) | 86.5 (85.0–87.9) | 81.5 (79.2–83.6) |
| Specified histologic subtypes | ||||||||
| Primarily malignant | ||||||||
| Diffuse astrocytoma | 342 | 68.2 (62.8–72.9) | 57.9 (52.3–63.1) | 53.6 (47.9–58.8) | 46.8 (41.2–52.2) | 39.1 (33.5–44.7) | 30.7 (24.9–36.6) | 27.6 (21.4–34.1) |
| Anaplastic astrocytoma | 859 | 61.2 (57.8–64.4) | 51.9 (48.5–55.3) | 44.4 (40.9–47.8) | 37.1 (33.7–40.5) | 27.9 (24.7–31.2) | 21.8 (18.6–25.2) | 19.8 (16.4–23.5) |
| Glioblastoma | 5,991 | 30.3 (29.1–31.5) | 15.9 (15.0–16.9) | 9.5 (8.7–10.3) | 5.4 (4.8–6.0) | 3.6 (3.1–4.2) | 2.9 (2.4–3.5) | 2.8 (2.2–3.5) |
| Oligodendroglioma | 785 | 93.4 (91.3–95.0) | 90.3 (87.9–92.3) | 89.1 (86.6–91.2) | 84.6 (81.6–87.1) | 78.2 (74.7–81.3) | 61.9 (57.2–66.3) | 51.0 (45.0–56.6) |
| Anaplastic oligodendroglioma | 205 | 77.8 (71.4–83.0) | 70.7 (63.8–76.6) | 62.5 (55.2–69.0) | 57.4 (49.9–64.2) | 45.1 (37.2–52.6) | 35.4 (26.1–44.8) | 35.4 (26.1–44.8) |
| Mixed glioma | 293 | 84.7 (80.0–88.5) | 78.3 (73.0–82.7) | 71.6 (65.8–76.5) | 64.7 (58.6–70.1) | 55.3 (48.8–61.4) | 44.3 (37.1–51.3) | 38.9 (31.0–46.8) |
| Astrocytoma (NOS) | 1,722 | 64.5 (62.1–66.8) | 57.0 (54.6–59.4) | 53.5 (51.0–55.9) | 49.3 (46.8–51.7) | 42.9 (40.4–45.4) | 38.3 (35.6–41.0) | 36.9 (33.9–39.9) |
| Glioma, malignant (NOS) | 829 | 53.9 (50.4–57.3) | 46.1 (42.5–49.6) | 42.9 (39.4–46.4) | 40.2 (36.7–43.8) | 37.3 (33.6–41.0) | 36.5 (32.7–40.2) | 35.1 (30.2–40.0) |
| Embryonal/primitive medulloblastoma | 542 | 81.7 (78.1–84.7) | 75.3 (71.4–78.8) | 73.0 (69.1–76.6) | 68.1 (63.9–71.9) | 61.9 (57.5–66.0) | 54.0 (49.2–58.6) | 49.8 (44.4–55.0) |
| Lymphoma | 886 | 45.9 (42.5–49.2) | 38.5 (35.2–41.8) | 34.5 (31.3–37.8) | 28.6 (25.4–31.8) | 21.3 (18.3–24.5) | 15.7 (12.5–19.2) | 13.0 (9.3–17.4) |
| Meningioma, malignant | 228 | 86.0 (80.1–90.3) | 82.3 (75.8–87.2) | 80.2 (73.3–85.5) | 74.6 (67.2–80.6) | 67.3 (58.6–74.6) | 53.5 (42.5–63.3) | 36.9 (23.2–50.8) |
| Neoplasm, unspecified | 666 | 35.5 (31.7–39.3) | 32.2 (28.5–36.0) | 30.4 (26.6–34.2) | 27.9 (24.2–31.8) | 27.7 (23.8–31.7) | 27.7 (23.8–31.7) | 27.7 (23.8–31.7) |
| Ependymoma | 532 | 92.8 (92.2–93.4) | 90.4 (87.4–92.7) | 88.7 (85.4–91.2) | 84.3 (80.6–87.4) | 81.5 (77.4–84.9) | 75.4 (70.4–79.7) | 69.9 (62.8–75.9) |
| Germ cell tumor | 172 | 91.4 (86.0–94.7) | 88.5 (82.6–92.5) | 86.1 (79.9–90.6) | 85.6 (79.3–90.1) | 82.9 (76.1–88.0) | 79.5 (71.6–85.5) | 73.1 (61.7–81.6) |
| Primarily nonmalignant | ||||||||
| Pilocytic astrocytoma | 663 | 96.5 (94.8–97.7) | 96.3 (94.5–97.5) | 95.8 (93.9–97.2) | 95.1 (93.1–96.6) | 92.7 (90.2–94.6) | 92.0 (89.3–94.0) | 89.8 (85.3–93.0) |
| Hemangioblastoma/hemangioma | 224 | 94.0 (89.6–96.5) | 93.6 (89.0–96.3) | 93.6 (89.0–96.3) | 93.1 (87.9–96.1) | 90.4 (84.0–94.3) | 88.3 (79.4–93.5) | 80.4 (67.2–88.7) |
| Craniopharyngioma | 135 | 93.0 (86.8–96.4) | 90.4 (83.4–94.5) | 89.2 (81.8–93.7) | 88.9 (81.2–93.6) | 84.8 (75.7–90.6) | 73.8 (62.7–82.0) | 70.1 (55.7–80.6) |
| Meningioma, nonmalignant | 4,535 | 91.9 (90.9–92.7) | 91.4 (90.4–92.4) | 91.0 (89.9–92.0) | 90.4 (89.1–91.5) | 88.7 (87.1–90.1) | 82.8 (80.2–85.0) | 77.3 (73.4–80.7) |
| Nerve sheath and other cranial/spinal nerve tumor | 1,125 | 98.4 (97.1–99.1) | 98.0 (96.6–98.9) | 97.7 (96.1–98.7) | 97.5 (95.7–98.6) | 97.5 (95.7–98.6) | 97.4 (92.2–99.1) | 97.4 (92.2–99.1) |
| Pituitary tumor | 1,609 | 97.2 (96.0–98.0) | 97.2 (96.0–98.0) | 96.8 (95.4–97.8) | 96.3 (94.6–97.5) | 93.7 (91.4–95.3) | 90.2 (86.8–92.7) | 81.6 (76.7–85.5) |
| 73.8 (66.3–79.9) | 68.6 (58.6–76.7) | |||||||
| Neuronal/glial, nonmalignant and malignant | 254 | 91.6 (87.3–94.5) | 86.8 (81.7–90.5) | 85.2 (79.9–89.1) | 84.0 (78.6–88.2) | 78.2 (71.7–83.3) | ||
| All other brain tumors | 334 | 82.3 (77.6–86.1) | 78.3 (73.3–82.5) | 75.7 (70.5–80.2) | 72.3 (66.8–77.1) | 66.2 (60.2–71.6) | 61.6 (54.6–67.8) | 57.7 (49.1–65.3) |
NOS = Not otherwise specified.